SMTL ID : 7xrr.1

Crystal structure of the human OX2R bound to the insomnia drug lemborexant.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

monomer

Ligands

1 x NRK: (1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-~{N}-(5-fluoranylpyridin-2-yl)-2-(3-fluorophenyl)cyclopropane-1-carboxamide(Non-covalent)

NRK.1: 15 residues within 4Å: Chain A: A.82, T.83, V.86, D.87, W.92, I.102, P.103, Q.106, T.107, V.110, Q.159, F.199, I.261, N.265, H.291 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:T.83, A:V.86, A:P.103, A:T.107, A:I.261, A:N.265 Hydrogen bonds: A:Q.106, A:Q.159 pi-Stacking: A:F.199, A:H.291

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Asada, H. et al., Molecular basis for anti-insomnia drug design from structure of lemborexant-bound orexin 2 receptor. Structure (2022)

Release Date

2022-11-23

Peptides

Orexin receptor type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Orexin receptor type 2